Registry Maastro Applicator

Conditions

• Rectal Cancer

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Study Details

This registry will collect data from all patients treated with the MAASTRO HDR applicator. The goal is to deepen knowledge about dose-response relationships in rectal cancer boosting, which is essential for improving future treatment approaches and patient selection.

Key Dates

First listed

Mar 30, 2026

Start date

Mar 23, 2026

Status verified

Apr 2026

Primary completion

Apr 1, 2034

Completion

Dec 31, 2034

Study Design

Enrollment

999 participants (estimated)

Arms

• Arm: Patients being treated with the MAASTRO HDR rectal applicator
  Treatment with the MAASTRO HDR rectal applicator

Primary Outcome Measure

Efficacy of Maastro applicator endoluminal HDR contact brachytherapy boosting in functional organ sparing of the rectum. [ Time Frame: From enrollment to the end of FU at 10 years ]

Central Contacts

• Ann Claessens
  +31 88 44 55 600
  [email protected]

Find similar trials

Related Studies

• Integrated Cancer Repository for Cancer Research
  Recruiting · University of Nebraska · Greenwood Village, Colorado
• Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
  PHASE1/PHASE2 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
• Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
  PHASE1/PHASE2 · Recruiting · Washington University School of Medicine · Boston, Massachusetts
• Exosomes in Rectal Cancer
  Recruiting · University of Kansas Medical Center · Kansas City, Kansas